COLGATE PALMOLIVE CO

Listed Company

CLCIK 0000021665NYSELarge AcceleratedPerfumes, Cosmetics & Other Toilet PreparationsDelawareFY ends Dec 31

Period

FY 2025

Revenue

$20.38B

Net Income

$2.13B

Total Assets

$16.33B

Equity

$54.00M

Shares Out

801.55M

Op. Cash Flow

$4.20B

Business

Colgate-Palmolive Company is a global consumer products company that develops, manufactures and markets science-led products aimed at improving oral health, personal care, home care and pet nutrition. Its main products include toothpastes, toothbrushes, mouthwashes, soaps, shampoos, deodorants, household cleaners, dishwashing and fabric care products, and specialty and therapeutic pet foods marketed under consumer and professional brands. The company operates through two principal segments: Oral, Personal and Home Care, and Pet Nutrition (Hill’s). Its products are sold in over 200 countries through retailers, wholesalers, distributors, veterinarians, eCommerce channels and direct-to-consumer.

Summary from filing dated 2025-02-13

Financials

Consolidated Statement of Income

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Net sales	20,382	20,101	19,457	17,967	17,421
Cost of sales	8,131	7,940	8,131	7,719	7,046
Gross profit	12,251	12,161	11,326	10,248	10,375
Selling, general and administrative expenses	7,903	7,729	7,151	6,565	6,407
Other (income) expense, net	123	164	191	69	65
Goodwill and intangible assets impairment charges	919	0	0	721	571
Operating profit	3,306	4,268	3,984	2,893	3,332
Non-service related postretirement costs	55	87	360	80	70
Interest expense	267	292	287	167	—
Interest income	75	67	55	14	—
Income before income taxes	3,059	3,956	3,392	2,660	3,087
Global effective tax rate	798	907	937	693	749
Net income including noncontrolling interests	2,261	3,049	2,455	1,967	2,338
Less: Net income attributable to noncontrolling interests	129	160	155	182	172
Net income attributable to Colgate-Palmolive Company	2,132	2,889	2,300	1,785	2,166
Earnings per common share, basic (in dollars per share)	2.64	3.53	2.78	2.13	2.56
Earnings per common share, diluted (in dollars per share)	2.63	3.51	2.77	2.13	2.55

Consolidated Balance Sheet

As of · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Cash and cash equivalents	1,288	1,096	966	775	832
Receivables (net of allowances of $90 and $85, respectively)	1,675	1,521	1,586	1,504	1,297
Inventories	2,032	1,987	1,934	2,074	1,692
Other current assets	714	713	793	760	576
Total current assets	5,709	5,317	5,279	5,113	4,397
Property, plant and equipment, net	4,660	4,422	4,582	4,307	3,730
Goodwill	3,122	3,272	3,410	3,352	3,284
Other intangible assets, net	1,536	1,756	1,887	1,920	2,462
Deferred income taxes	205	195	214	135	193
Other non-current assets	1,098	1,084	1,021	904	974
Total assets	16,330	16,046	16,393	15,731	15,040
Debt payable within one-year	1,117	660	330	11	39
Accounts payable	2,089	1,805	1,698	1,551	1,479
Accrued income taxes	383	403	336	317	436
Other accruals	3,264	2,891	2,377	2,111	2,085
Total current liabilities	6,853	5,759	4,741	4,004	4,051
Long-term debt	6,871	7,289	8,219	8,741	7,194
Deferred income taxes	181	343	361	383	395
Other non-current liabilities	2,060	2,111	2,115	1,797	2,429
Total liabilities	15,965	15,502	15,436	14,925	14,069
Commitments and contingent liabilities	0	0	0	0	0
Common stock, $1 par value (2,000,000,000 shares authorized, 1,465,706,360 shares issued)	1,466	1,466	1,466	1,466	1,466
Additional paid-in capital	4,322	4,181	3,808	3,546	3,269
Retained earnings	26,595	26,145	25,289	24,573	24,350
Accumulated other comprehensive income (loss)	−3,879	−4,222	−3,937	−4,055	−4,386
Treasury stock, at cost	−28,450	−27,358	−26,017	−25,128	−24,089
Total Colgate-Palmolive Company shareholders equity	54	212	609	401	609
Noncontrolling interests	311	332	348	405	362
Total equity	365	544	957	806	971
Total liabilities and equity	16,330	16,046	16,393	15,731	15,040

Consolidated Statement of Cash Flows

Year Ended · In millions, except per-share amounts

Concept	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2023 2023-12-31	FY 2022 2022-12-31	FY 2021 2021-12-31
Depreciation and amortization	630	605	567	545	556
ERISA litigation matter	65	0	267	0	0
Restructuring and termination benefits, net of cash	−7	51	−23	49	−21
Stock-based compensation expense	155	135	122	125	135
Deferred income taxes	−109	−77	−98	−78	−132
Receivables	−16	−56	−37	−227	−84
Inventories	109	−100	194	−333	−72
Accounts payable and other working capital	251	516	309	—	—
Other non-current assets	35	28	53	—	—
Other non-current liabilities	−95	−44	−64	—	—
Net cash provided by operations	4,198	4,107	3,745	2,556	3,325
Capital expenditures	−564	−561	−705	−696	−567
Purchases of marketable securities and investments	−698	−574	−506	−470	−141
Proceeds from sale of marketable securities and investments	752	564	502	322	141
Payment for acquisitions, net of cash acquired	−293	0	0	−809	0
Other investing activities	−14	37	−33	5	−25
Net cash used in investing activities	−817	−534	−742	−1,601	−592
Short-term borrowing (repayment) less than 90 days, net	−989	93	−906	540	−171
Principal payments on debt	−655	−503	−903	−406	−703
Proceeds from issuance of debt	1,188	2	1,495	1,513	699
Dividends paid	−1,823	−1,789	−1,749	−1,691	−1,679
Purchases of treasury shares	−1,210	−1,739	−1,128	−1,308	−1,320
Proceeds from exercise of stock options	101	638	380	418	424
Other financing activities	132	−91	18	−18	−24
Net cash used in financing activities	−3,256	−3,389	−2,793	−952	−2,774
Effect of exchange rate changes on Cash and cash equivalents	67	−54	−19	−60	−15
Net increase (decrease) in Cash and cash equivalents	192	130	191	−57	−56
Income taxes paid	913	933	937	945	890
Interest paid	270	302	280	151	194

Filings

Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro

Material Events

Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro

Insiders

Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro

Institutional Holders

Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro